Showing results (441-450 of 2,462) with videos related to
Sort By:
Pageof 247
Journal of Gastrointestinal Oncology|November 12, 2025
ZNF529 up-regulation speeds up progression and induces tyrosine kinase inhibitor resistance in hepatocellular carcinomaKai Qin, Sheng-Sheng Zhou, Jian-Di Li, et al.Journal of Gastrointestinal Oncology|November 12, 2025
Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registryFaisal Hayat, Simon Chiu, Ashleigh Stuart, et al.Journal of Gastrointestinal Oncology|November 12, 2025
CYSTM1 is a potential diagnostic and prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinomaNing Zhang, Junling Zhen, Xiangnan KongJournal of Gastrointestinal Oncology|November 12, 2025
Prognostic and safety analysis of capecitabine monotherapy versus CapeOx (capecitabine plus oxaliplatin) in elderly patients with high-risk stage II and stage III MRD-negative colorectal cancerJiawei Zhai, Rongjian Tan, Wenting Ou, et al.Journal of Gastrointestinal Oncology|November 12, 2025
Body mass index-defined overweight (but not obese) correlates with better postoperative prognosis in colorectal cancerXiujie Shu, Ziwei Wang, Xiaoyan LiangJournal of Gastrointestinal Oncology|November 12, 2025
Trends and incidence of stomach cancer in middle-aged and elderly populations: a global burden of disease analysisYubao Tang, Danyang Wang, Zhicheng Xu, et al.Journal of Gastrointestinal Oncology|November 12, 2025
Integrated bioinformatic and machine learning analysis identifies MCM7 and ADAM17 as potential biomarkers for early stage gastric cancerFei Li, Gang Liu, Jin Wang, et al.Journal of Gastrointestinal Oncology|November 12, 2025
ISM2 as a prognostic biomarker and mediator of immune infiltration in colorectal cancer: evidence from bioinformatics and experimental analysisWen-Hui Qiang, Ran Ji, Xiao-Yun Yan, et al.Journal of Gastrointestinal Oncology|November 12, 2025
Expression and clinical significance of ERBB4 in gastric cancerXiaofeng Zhou, Siyu Zhao, Lin Zheng, et al.Journal of Gastrointestinal Oncology|November 12, 2025
Construction of a predictive model for gemcitabine combined with cisplatin resistance in intrahepatic cholangiocarcinoma based on multidimensional inflammatory indicesXiaofeng Zhou, Yu ShiPageof 247